Skip to content

Homoeopathy as adjuvant in management of coronavirus infection

HOMOEOPATHY AS AN ADJUVANT TO STANDARD TREATMENT PROTOCOL IN MANAGEMENT OF CORONA VIRUS INFECTION- A RANDOMISED, PLACEBO CONTROLLED, OPEN LABEL STUDY

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024925
Enrollment
300
Registered
2020-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Homoeopathic Medicine: Homoeopathic medicines will be given as adjuvant to the standard care. Medicine will be selected based on sign s and symptoms of patients keeping in view homoeopa

Sponsors

Bajaj Auto Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Hospitalized symptomatic patients with confirmed COVID-19 and are 2. Age between 18 years to 80 years of both gender 3. Willing to give signed written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients on ventilatory support 2. Immunocompromised patients 3. Severe heart, lung, kidney, brain, blood diseases or other important systemic diseases 4. Subjects considered to be unable to complete the study, or not suitable for the study by researchers.

Design outcomes

Primary

MeasureTime frame
Clinicalrecoveryofpatientorrequirementoflifesupport(ventilator)/death. Timepoint: Every 24 hours

Secondary

MeasureTime frame
i. Time to fever clearance ii. Change in severity of symptoms as per clinical syndromes associated with COVID - 19 infection. iii. Time to resolution of pneumonia iv. Time to recovery in terms of 2 negative test for Covid-19 v. Period of hospital stay vi. Requirement of conventional medication till clinical improvement Timepoint: Every 24 hours

Countries

India

Contacts

Public ContactDr Ayushi Shrikhande

CCRH

anilnaman@rediffmail.com9911127619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026